DE60304590D1 - Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen - Google Patents

Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen

Info

Publication number
DE60304590D1
DE60304590D1 DE60304590T DE60304590T DE60304590D1 DE 60304590 D1 DE60304590 D1 DE 60304590D1 DE 60304590 T DE60304590 T DE 60304590T DE 60304590 T DE60304590 T DE 60304590T DE 60304590 D1 DE60304590 D1 DE 60304590D1
Authority
DE
Germany
Prior art keywords
disorder
pressively
benzodioxanes
heterocyclic
condensed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60304590T
Other languages
English (en)
Other versions
DE60304590T2 (de
Inventor
Paul Stack
Ann Evrard
Shantilal Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of DE60304590D1 publication Critical patent/DE60304590D1/de
Publication of DE60304590T2 publication Critical patent/DE60304590T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE60304590T 2002-09-12 2003-09-11 Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen Expired - Fee Related DE60304590T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41007202P 2002-09-12 2002-09-12
US410072P 2002-09-12
US10/659,174 US6911445B2 (en) 2002-09-12 2003-09-10 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
US659174 2003-09-10
PCT/US2003/028459 WO2004024732A1 (en) 2002-09-12 2003-09-11 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans

Publications (2)

Publication Number Publication Date
DE60304590D1 true DE60304590D1 (de) 2006-05-24
DE60304590T2 DE60304590T2 (de) 2007-05-10

Family

ID=31997897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60304590T Expired - Fee Related DE60304590T2 (de) 2002-09-12 2003-09-11 Antidepressiv wirkende cycloalkylaminderivate von mit heterocyclen kondensierten benzodioxanen

Country Status (21)

Country Link
US (1) US6911445B2 (de)
EP (1) EP1546151B1 (de)
JP (1) JP2006503040A (de)
KR (1) KR20050042187A (de)
CN (1) CN1309722C (de)
AT (1) ATE323094T1 (de)
AU (1) AU2003266029A1 (de)
BR (1) BR0314430A (de)
CA (1) CA2498131A1 (de)
DE (1) DE60304590T2 (de)
DK (1) DK1546151T3 (de)
EC (1) ECSP055659A (de)
ES (1) ES2259776T3 (de)
HK (1) HK1073849A1 (de)
MX (1) MXPA05002838A (de)
NO (1) NO20051770L (de)
NZ (1) NZ539253A (de)
PT (1) PT1546151E (de)
RU (1) RU2005107591A (de)
SI (1) SI1546151T1 (de)
WO (1) WO2004024732A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060373A1 (es) 2004-06-24 2006-04-29 Smithkline Beecham Corp Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2
PE20060748A1 (es) 2004-09-21 2006-10-01 Smithkline Beecham Corp Derivados de indolcarboxamida como inhibidores de quinasa ikk2
CA2597616A1 (en) * 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
US20080139546A1 (en) * 2006-09-29 2008-06-12 Wyeth Tetrahydroquinoline, indoline, and related aniline derivatives of heterocycle-fused benzodioxan methylamines
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
WO2008150848A1 (en) * 2007-05-30 2008-12-11 Wyeth Antidepressant heteroaryl derivatives of heterocycle-fused benzodioxans
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
US5468767A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antidepressant 3-(aminocycloalkenyl)-indole-5-nitrile derivatives
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
GB9627005D0 (en) 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents
GB9704948D0 (en) * 1997-03-11 1997-04-30 Knoll Ag Therapeutic agents
CA2327360A1 (en) * 1998-04-08 1999-10-14 Richard Eric Mewshaw Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
US6162803A (en) * 1998-04-08 2000-12-19 American Home Products Corp. Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression
WO2002072587A1 (en) 2001-03-14 2002-09-19 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline
ATE279415T1 (de) 2001-04-26 2004-10-15 Wyeth Corp Antidepressiv wirksame azaheterocyclymethyl- derivative von oxaheterocycyl-anellierten (1,4)- benzodioxanen

Also Published As

Publication number Publication date
NO20051770L (no) 2005-06-07
HK1073849A1 (en) 2005-10-21
MXPA05002838A (es) 2005-08-16
PT1546151E (pt) 2006-07-31
CN1309722C (zh) 2007-04-11
SI1546151T1 (sl) 2006-08-31
DE60304590T2 (de) 2007-05-10
DK1546151T3 (da) 2006-07-31
RU2005107591A (ru) 2006-01-20
BR0314430A (pt) 2005-09-27
EP1546151B1 (de) 2006-04-12
WO2004024732A1 (en) 2004-03-25
JP2006503040A (ja) 2006-01-26
CN1681821A (zh) 2005-10-12
EP1546151A1 (de) 2005-06-29
ES2259776T3 (es) 2006-10-16
ECSP055659A (es) 2005-07-06
CA2498131A1 (en) 2004-03-25
NZ539253A (en) 2006-09-29
US6911445B2 (en) 2005-06-28
AU2003266029A1 (en) 2004-04-30
US20040171667A1 (en) 2004-09-02
KR20050042187A (ko) 2005-05-04
ATE323094T1 (de) 2006-04-15

Similar Documents

Publication Publication Date Title
NO20051770L (no) Antidepressivt virkende cykloalkylaminderivater av heterocykle-kondenserte benzodioksaner
NO20051769L (no) Antidepressivt virkende azaheterocykylmetylderivater av heterocykluskondenserte benzodioksaner
NO20054223L (no) Antistoffmolekyler som har spesifisitet for human IL-1beta
MY147217A (en) Antibody molecules having specificity for human il-06
BRPI0516735B8 (pt) métodos para produção de (r)-2-acetamido-n-benzil-3-metoxipropionamida (lacosamida) e de uma formulação farmacêutica, e uso de (r)-n-benzil-2-nboc-amino-3-metoxipropionamida (c-937)
ECSP055660A (es) Antidepresivos derivados de indolalquilo de benzodioxan metilaminas de heterociclo fusionado
BR0314277A (pt) Composto; método de tratamento de um indivìduo acometido por uma condição de depressão, ansiedade, distúrbios do pânico, de tensão pós-traumática, disfórico pré-menstrual, de deficiência da atenção, obsessivos-compulsivos e alimentares, obesidade, rubor vasomotor, dependência de álcool e cocaìna e disfunção sexual; composição farmacêutica e uso do mesmo
BRPI0607224A2 (pt) processo para preparação de ciclohexanona e ciclohexanol
ATE281459T1 (de) Azaheterocyclylmethyl derivative des 2,3-dihydro- 1,4-dioxino(2,3-f)quinolins als antidepressiva
NO20051617L (no) Piperidinderivater av heterocyklusfusjonerte benzodioksaner med antidepressiv aktivitet
NO20064012L (no) Kjemisk prosess
WO2002088136A3 (en) Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene
BR0209343A (pt) Antidepressivos de azaheterociclilmetila derivados de [1,4]-benzodioxanos oxaheterociclo-fundidos; métodos de tratamento usando tais compostos; processo para prepará-los
BR0209407A (pt) Antidepressivos de azaheterociclilmetila derivados de 7,8-dihidro-1,6,9-trioxa-3-aza-ciclopenta[a[]naftaleno , método de tratamento usando tais compostos e processo para prepará-los
DE60213576D1 (de) ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL-DERIVATE VON 2,3-DIHYDRO-1,4-DIOXINOi2,3-föCHINOXALIN
BRPI0508059A (pt) método para preparação de pirrolidina oximas
BR0314280A (pt) Composto; método de tratamento de um indivìduo acometido por uma condição de depressão, ansiedade, distúrbios do pânico, de tensão pós-traumática, disfórico pré-menstrual, de deficiência da atenção, obsessivos-compulsivos e alimentares, obesidade, rubor vasomotor, dependência de álcool e cocaìna e disfunção sexual; composição farmacêutica e uso do mesmo
EA200501577A1 (ru) Производные 4-(2-фенилсульфанилфенил)пиперидина в качестве ингибиторов повторного поглощения серотонина
DE502006008280D1 (de) Imino-oxazolidine und ihre verwendung als antikoagulantien
CR7726A (es) Antidepresivos derivados de indoalquilo de benzodioxan metilaminas de heterociclo fusionado
ATE417055T1 (de) Steroid modifizierte solatriosen
UA96731C2 (en) Process for preparing cyclohexanone and cyclohexanol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee